Treatment Of Micro-organisms Or Enzymes With Electrical Or Wave Energy (e.g., Magnetism, Sonic Waves, Etc.) Patents (Class 435/173.1)
-
Patent number: 12077736Abstract: An improved system of generating renewable energy is comprised of a specific configuration of mechanisms, materials, and processes that all function together as a single symbiotic system. In accordance with a preferred embodiment, the system cultivates aquatic biomass, then extracts triglycerides from said biomass. The extracted triglycerides are converted into biodiesel through transesterification. During the operation of the system, a continuous output of biofuel, thermal energy, steam, and electricity, is efficiently produced. These yields are precisely measured and repurposed as energy input at various points throughout system processes, thus resulting in a surplus output. Any embodiment of the disclosed system will generate a continuously renewable final product of biofuel and power.Type: GrantFiled: April 12, 2015Date of Patent: September 3, 2024Inventor: Dennis Steele
-
Patent number: 11684871Abstract: Assemblies, systems, and methods for isolation of target material are provided. In various embodiments, an assembly for target material isolation includes a housing having an upper portion and a lower portion together defining an inner chamber. The inner chamber includes a semi-toroidal shape and the semi-toroidal shape defines a longitudinal axis. The assembly further includes one or more fluidic connection from the exterior of the housing to the inner chamber. An isolation material (e.g., polymer wool and/or magnetic beads) may be disposed within the inner chamber. A system includes a configured to fit at least a portion of the housing and releasably couple the assembly. Upon activation of the motor, the assembly may rotate about the longitudinal axis. An angle of the platform may be adjustable to thereby change the angle of the longitudinal axis about which the assembly rotates.Type: GrantFiled: April 6, 2021Date of Patent: June 27, 2023Assignee: AnuCell Biosystems LimitedInventors: John Daly, Kieran Curran, Macdara Glynn, Mark McCabe, David Merrigan, Jason Ryan, John P. Griffin, Caitriona Ryan, Martin Reddin
-
Patent number: 11655466Abstract: The present invention provides systems, methods, and devices for electroporation-based therapies (EBTs). Embodiments provide patient-specific treatment protocols derived by the numerical modeling of 3D reconstructions of target tissue from images taken of the tissue, and optionally accounting for one or more of physical constraints or dynamic tissue properties. The present invention further relates to systems, methods, and devices for delivering bipolar electric pulses for irreversible electroporation exhibiting reduced or no damage to tissue typically associated with an EBT-induced excessive charge delivered to the tissue.Type: GrantFiled: July 24, 2015Date of Patent: May 23, 2023Assignee: Virginia Tech Intellectual Properties, Inc.Inventors: Robert E. Neal, II, Paulo A. Garcia, Rafael V. Davalos, John H. Rossmeisl, John L. Robertson
-
Patent number: 11427804Abstract: A method and related apparatus for confirming whether a kill laser successfully destroys an undesired population of cells includes introducing fluorescent dye into cells, exciting the cells with a detection laser or a light emitting diode to cause the cell to fluoresce for a first time, measuring the amount of fluorescence in the cells with a detector capable of emitting a detection pulse, classifying the cells via embedded processing as undesired or desired cells based on the amount of fluorescence, firing a kill beam with a kill laser at any undesired cells, measuring the amount of fluorescence in the cells a second time to determine whether a fluorescent event was generated from the kill beam striking the cells, and providing feedback to an operator of the kill laser as to whether any fluorescent events were generated from the kill beam striking the cells.Type: GrantFiled: June 14, 2019Date of Patent: August 30, 2022Assignee: ABS Global, Inc.Inventors: Frederick Hershel Savage, David Appleyard, Zheng Xia, Matthew Ebersole, Daniel McAda
-
Patent number: 11408821Abstract: The present invention relates to fluorescence imaging. In order to enhance compatibility with multiple fluorescence channels for calibrating a fluorescence microscope, a calibration slide is provided that comprises a substrate and a pixel layout. The pixel layout comprises a plurality of spaced apart metal nanostructures arranged on a surface of the substrate. The metal nanostructures are arranged to produce plasmon resonances that allow absorbing light at an excitation wavelength to produce photo-luminescence and/or fluorescence light for generating a fluorescent image. The fluorescent image comprises a plurality of pixel intensity values that are provided for calibration of a fluorescence microscope.Type: GrantFiled: June 15, 2018Date of Patent: August 9, 2022Assignee: KONINKLIJKE PHILIPS N.V.Inventors: Marius Iosif Boamfa, Susanne Maaike Valster, Marcus Antonius Verschuuren
-
Patent number: 11369965Abstract: A PCR amplification and product detection system is disclosed. The system utilizes a uniform and direct photonic heating subsystem to mediate reaction-by-reaction, high-throughput PCR amplification detectable by a fluorescence detection subsystem. Reaction-by-reaction temperature monitoring for dynamic feedback heat regulation is also disclosed. Also disclosed are methods for using the same.Type: GrantFiled: March 8, 2017Date of Patent: June 28, 2022Inventors: Ronald L. Biro, Beau Hunt
-
Patent number: 11366116Abstract: The present invention relates, in part, to systems configured to obtain samples from an organism in an autonomous manner. Such systems can employ a cartridge configured to provide bait to attract an organism, as well as channels to store and/or test samples obtained from the organism.Type: GrantFiled: April 12, 2018Date of Patent: June 21, 2022Assignee: National Technology & Engineering Solutions of Sandia, LLCInventors: Robert Meagher, Ronald F. Renzi, Cameron Scott Ball, Aashish Priye, Jonathan Ivers Helm, Bryan Carson, Stanley Alan Langevin
-
Patent number: 11318304Abstract: The present invention provides a system and a method for measuring an impedance of one or more target cells before and after an electroporation protocol has been applied to the one or more target cells. A result of the impedance measurement provides a feedback control that can be implemented during and/or after the electroporation protocol to customize an electrical treatment for a particular target cell or cellular tissue.Type: GrantFiled: September 29, 2017Date of Patent: May 3, 2022Assignee: University of South FloridaInventors: Mark Jeffrey Jaroszeski, Timothy Fawcett, Richard Jason Connolly, Andrew M. Hoff, Reginald Morley Atkins, Douglas Walter Brown, Richard A. Gilbert
-
Patent number: 11318305Abstract: An adaptive control method for controlling EP pulse parameters during electroporation (EP) of cells or tissue using an EP system includes providing a system for adaptive control to optimize EP pulse parameters including EP pulse parameters, applying voltage and current excitation signals to the cells, obtaining data from the current and voltage measurements, and processing the data to separate the desirable data from the undesirable data, extracting relevant features from the desirable data, applying at least a portion of the relevant features to a trained diagnostic model, estimating EP pulsing parameters based on an outcome of the applied relevant features, where the initialized EP pulsing parameters are based on the trained model and the relevant features, to optimize the EP pulsing parameters, and applying, by the generator, a first EP pulse based on the first pulsing parameters.Type: GrantFiled: March 31, 2016Date of Patent: May 3, 2022Assignee: ONCOSEC MEDICAL INCORPORATEDInventors: Arya Bahrami, Douglas W. Brown, Jean Campbell, Richard J. Connolly, Andy E. Denison, Christopher S. Hayden, Eric T. Johnson, Robert H. Pierce, Robert R. Ragland
-
Patent number: 11293029Abstract: Provided are native promoters comprising polynucleotides isolated from Corynebacterium glutamicum, and mutant promoters derived therefrom, which may be used to regulate, i.e., either increase or decrease, gene expression. Also provided are promoter ladders comprising a plurality of the promoters having incrementally increasing promoter activity. Also provided are host cells and recombinant vectors comprising the promoters, and methods of expressing genes of interest and producing biomolecules using the host cells.Type: GrantFiled: December 7, 2016Date of Patent: April 5, 2022Assignee: Zymergen Inc.Inventors: Zachariah Serber, Katherine G. Gora, Shawn P. Manchester
-
Patent number: 11287363Abstract: The present invention provides systems and methods for using acoustic radiation pressure to fractionate particles within a fluid.Type: GrantFiled: October 15, 2019Date of Patent: March 29, 2022Assignee: Triad National Security, LLCInventors: Gregory Kaduchak, Michael D. Ward
-
Patent number: 11254926Abstract: The present invention provides systems, methods, and devices for electroporation-based therapies (EBTs). Embodiments provide patient-specific treatment protocols derived by the numerical modeling of 3D reconstructions of target tissue from images taken of the tissue, and optionally accounting for one or more of physical constraints or dynamic tissue properties. The present invention further relates to systems, methods, and devices for delivering bipolar electric pulses for irreversible electroporation exhibiting reduced or no damage to tissue typically associated with an EBT-induced excessive charge delivered to the tissue.Type: GrantFiled: May 6, 2019Date of Patent: February 22, 2022Assignee: Virginia Tech Intellectual Properties, Inc.Inventors: Robert E. Neal, II, Paulo A. Garcia, Rafael V. Davalos, John H. Rossmeisl, John L. Robertson
-
Patent number: 11214816Abstract: The present invention relates to a recombinant microorganism having heterologous genes introduced thereto and a method for producing a useful material from formic acid and carbon dioxide using the microorganism. The present invention provides a novel microorganism having a cyclic metabolic pathway introduced thereto through which C3 or higher carbon organic compounds can be synthesized from formic acid and carbon dioxide, whereby carbon dioxide rich in nature and formic acid that is of low toxicity and suitable for anabolic reaction in view of reaction kinetics and which can be easily and rapidly synthesized from carbon dioxide can be used to effectively synthesize the C3 organic compound pyruvic acid from which various high-value added compound can be synthesized.Type: GrantFiled: November 20, 2017Date of Patent: January 4, 2022Assignee: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Sang Yup Lee, Junho Bang
-
Patent number: 11123428Abstract: Provided is a method of reducing a number of viable microbes, including contacting microbes with an antibiotic compound and applying pulses of electricity having a duration of between about 50 nanoseconds and about 900 nanoseconds. The pulses of electricity may have an intensity between about 20 kV/cm and about 40 kV/cm. The pulses of electricity may be applied at a frequency of between about 0.1 Hz and about 10 Hz. The microbes may be a gram-negative or a gram-positive strain of bacteria and the antibiotic may be applied at a concentration for a duration, wherein applying the antibiotic to the strain at the concentration for the duration does not reduce a viable number of bacteria of the strain as much, or at all, when the pulses of electricity are not also applied.Type: GrantFiled: August 12, 2020Date of Patent: September 21, 2021Assignees: Purdue Research Foundation, Nanovis, LLCInventors: Allen Lawrence Garner, Ram Anand Vadlamani, David Alan Detwiler
-
Patent number: 10969383Abstract: The present disclosure generally pertains to a biomimetic apparatus configured to simulate physiological conditions by, in part, providing for both barrier and transport interfaces. The presently disclosed apparatus may be used to: test therapeutics for different diseases; to study transport; form a substrate for any organ tissue with a barrier and/or transport function; provide a closed loop assembly for fluid flow; mimic underlying and enveloped tissue; and model external environmental conditions.Type: GrantFiled: September 28, 2018Date of Patent: April 6, 2021Inventor: Karim I. Budhwani
-
Patent number: 10913943Abstract: Methods of enhancing stem cell therapy through the administration of low level light energy are provided in several embodiments. Some embodiments comprise irradiating stem cells before or after implantation at a target tissue having loss of function due to damage or disease, with a resultant increase in the efficacy of the cell therapy. In some embodiments, light energy enhances one or more of the viability, proliferation, migration or engraftment of the stem cells, thereby enhancing the therapeutic effects of the irradiated cells during cell therapy.Type: GrantFiled: November 14, 2018Date of Patent: February 9, 2021Assignee: Pthera LLCInventors: Jackson Streeter, Luis De Taboada
-
Patent number: 10843148Abstract: A new simple transfection method using an integrated electrowetting nano-injector (“INENI”) with controlled dosage delivery and high transfection efficiency is disclosed. The volume of delivery can be controlled via voltage application to an inner and outer electrode integrated into a nano-pipette. With higher voltages, more liquid enters the INENI and with lower voltages liquid is expelled. This method can be used to deliver plasmid DNA directly into the nuclei of cells. The INENI requires only the use of a single probe since both electrodes are integrated into the same nano-pipette. Hence, more space is available, and ergo the INENI offers a simplistic means for direct injection of metered amounts of exogenous material into the confines of a cell cytoplasm and/or nucleus while retaining full cell viability.Type: GrantFiled: June 19, 2018Date of Patent: November 24, 2020Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Hemantha K. Wickramasinghe, Elaheh Shekaramiz
-
Patent number: 10808262Abstract: The invention provides non-naturally occurring microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA. In some embodiments, the microbial organisms having such pathways also include pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation. The enhanced carbon flux through acetyl-CoA, in combination with pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation can, in some embodiments, be used for production of a bioderived compound. Accordingly, in some embodiments, the microbial organisms of the invention can include a pathway capable of producing a bioderived compound of the invention.Type: GrantFiled: November 25, 2014Date of Patent: October 20, 2020Assignee: Genomatica, Inc.Inventors: Robin E. Osterhout, Anthony P. Burgard, Priti Pharkya, Stefan Andrae
-
Patent number: 10450543Abstract: Provided herein is a pipette tip for electroporation including an outer surface, a void located within the outer surface, and a conductor located at least partially on or within the outer surface, in electrical communication with at least a portion of the outer surface and the void. Further provided herein is a pipette tip for electroporation including a body, a connector, and an elongated part. The connector is located at the distal end of the body and further includes at least one connecting post, a connecting part in mechanical communication with the connector, and a conductor located at least partially on or within the connector, wherein the conductor surrounds at least a portion of the connecting post. The elongated part also has a void and is located at the distal end of the connector. The void of the body, connector, and elongated part are in fluid communication.Type: GrantFiled: November 21, 2016Date of Patent: October 22, 2019Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Jun-Keun Chang, Keun-Chang Cho, Chan-Il Chung, Neon-Cheol Jung, Seung Gin Huh
-
Patent number: 10434086Abstract: Provided herein are methods and compositions that relate to, inter alia, CBL0137, a carbazole compound 1,1?-[9-[2-[(1-methylethyl)amino]ethyl]-9H-carbazole-3,6-diyl]bis-ethanone, useful for the treatment of various cancers, optionally in combination with various agents.Type: GrantFiled: April 6, 2015Date of Patent: October 8, 2019Assignee: Incuron, Inc.Inventor: Catherine Burkhart
-
Patent number: 10400208Abstract: A method of discriminating a living cell from a dead cell, and a device for implementing the method, the method including: using a lens-free imaging device to acquire a diffraction figure corresponding to a cell; and determining a light intensity on a central area of an elementary diffraction figure associated with the cell. It can thus be determined if the studied cell is a living cell or a dead cell.Type: GrantFiled: July 21, 2014Date of Patent: September 3, 2019Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESInventor: Cedric Allier
-
Patent number: 10365264Abstract: A measuring apparatus relates to a contractile ability of a spontaneously pulsating myocardial tissue. The measuring apparatus includes a measurement table and a pressure sensor. The measurement table includes a storage section having an opening and configured to hold liquid inside the storage section, and an attaching portion on which the myocardial tissue is attached around the opening. The pressure sensor is disposed inside the storage section.Type: GrantFiled: August 31, 2017Date of Patent: July 30, 2019Assignees: NIHON KOHDEN CORPORATION, TOKYO WOMEN'S MEDICAL UNIVERSITYInventors: Hirotsugu Kubo, Tatsuya Shimizu, Tetsutaro Kikuchi
-
Patent number: 10351811Abstract: A cell culture container characterized by being equipped with a container main body and a flat plate attached onto one surface of the container main body, wherein the container main body is equipped with an inflow port through which a liquid can flow into the container main body, a passage through which the liquid flowing into the container main body from the inflow port can pass, and an outflow port through which the liquid passing through the passage can flow out from the container main body, and wherein, on the bottom surface of the passage, multiple cell-seeding areas in which cells passing through the passage can be seeded are arranged side by side along the passage.Type: GrantFiled: August 18, 2016Date of Patent: July 16, 2019Assignee: SINFONIA TECHNOLOGY CO., LTD.Inventors: Tomoaki Kurakazu, Yasuhiro Oshima, Yoshio Kimura, Kenichi Kagawa, Shinichi Gomi, Shigenori Ozaki
-
Patent number: 10258987Abstract: The present invention generally relates to the manipulation of fluids using acoustic waves such as surface acoustic waves. In some aspects, one fluid may be introduced into another fluid via application of suitable acoustic waves. For example, a fluid may be added or injected into another fluid by applying acoustic waves where, in the absence of the acoustic waves, the fluid cannot be added or injected, e.g., due to the interface or surface tension between the fluids. Thus, for example, a fluid may be injected into a droplet of another fluid. Other embodiments of the invention are generally directed to systems and methods for making or using such systems, kits involving such systems, or the like.Type: GrantFiled: June 25, 2015Date of Patent: April 16, 2019Assignees: President and Fellows of Harvard College, The University Court of the University of GlasgowInventors: David A. Weitz, Thomas Franke
-
Patent number: 10219751Abstract: Methods, systems and related apparatus are provided to enable an electronic device to operate an external sensor comprising one or more emitters for emitting electromagnetic radiation of two different wavelengths and a detector for generating a response signal based on received electromagnetic radiation of the two different wavelengths connectable to an audio interface by applying a harmonic driving signal to a first contact and a second contact of the audio interface for driving the emitters of the external sensor, receiving the response signal at a third contact of the audio interface, demodulating and demultiplexing the response signal into a first wavelength response signal and a second wavelength response signal, analyzing the first and second wavelength response signals to determine one or more vital signs, and outputting the determined one or more vital signs.Type: GrantFiled: January 21, 2015Date of Patent: March 5, 2019Assignee: Lionsgate Technologies, Inc.Inventors: Christian Leth Petersen, John Mark Ansermino, Guy Dumont
-
Patent number: 10117701Abstract: A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable.Type: GrantFiled: March 5, 2015Date of Patent: November 6, 2018Assignee: The Regents of the University of CaliforniaInventors: Rafael Davalos, Boris Rubinsky
-
Patent number: 9938518Abstract: Devices are provided for inhibiting the electrical activity of an excitable cell through the application of a pulse of light which includes a substrate and a photoreactive film both of non-conducting material and laid directly on one another, in which the photoreactive film includes a layer of semiconductor polymer material and has an interface surface which can be placed in contact with an excitable cell and an electrolyte solution. After absorbing light, when placed in contact with the excitable cell and the electrolyte solution, the photoreactive film produces a potential difference across this interface surface which is capable of giving rise to hyperpolarization of the membrane of the excitable cell. Methods of inhibiting the electrical activity of excitable cells using such devices are also provided.Type: GrantFiled: August 1, 2014Date of Patent: April 10, 2018Assignees: FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, ISTITUTO DON CALABRIA—OSPEDALE CLASSIFICATO SACRO CUOREInventors: Diego Ghezzi, Fabio Benfenati, Guglielmo Lanzani, Maria Rosa Antognazza, Giuliano Freddi, Ilaria Donelli, Maurizio Mete, Grazia Pertile
-
Patent number: 9868938Abstract: Methods of generating cardiomyocytes from induced pluripotent stem cells (IPSCs) are provided. More specifically, the present disclosure relates to methods of generating cardiomyocytes from iPSCs using electrical stimulation. In some aspects, uses of such cells for therapeutics and in methods of treatment are provided.Type: GrantFiled: January 14, 2016Date of Patent: January 16, 2018Assignee: University of CincinnatiInventors: Yi-Gang Wang, Ha Won Kim, Ruilian Ma
-
Patent number: 9751057Abstract: A method of using a fluidics apparatus for lysing a cell. In the method, the cell is placed in a fluid sample contacting a substrate surface. The method further includes providing surface acoustic waves (SAWs) at the substrate surface, causing cell lyses.Type: GrantFiled: May 27, 2016Date of Patent: September 5, 2017Assignee: The University Court of the University of GlasgowInventors: Rab Wilson, Jonathan M. Cooper, Julien Reboud
-
Patent number: 9708597Abstract: In accordance with the present disclosure, exposure of a sample to one or more electric pulses via capacitive coupling is described. In certain embodiments, the sample may be a biological sample to be treated or modified using the pulsed electric fields. In certain embodiments, the electric pulses may be delivered to a load using capacitive coupling. In other embodiments, the electric pulses may be bipolar pulses.Type: GrantFiled: January 17, 2014Date of Patent: July 18, 2017Assignee: GENERAL ELECTRIC COMPANYInventors: Antonio Caiafa, Vasile Bogdan Neculaes, Allen Lawrence Garner, Andrew Soliz Torres
-
Patent number: 9688955Abstract: A material comprising positively and negatively charged nanoparticles, wherein one of said nanoparticles contained a magnetically responsive element, are combined with a support molecule, which is a long natural or synthetic molecule or polymer to make a magnetic nanoparticle assembly. When the magnetic nanoparticle assembly is combined with cells, it will magnetize those cells. The magnetized cells can then be washed to remove the magnetic nanoparticle assembly and the magnetized cells manipulated in a magnetic field.Type: GrantFiled: November 7, 2014Date of Patent: June 27, 2017Assignee: Nano3D Biosciences, Inc.Inventor: Glauco R. Souza
-
Patent number: 9663762Abstract: Methods for recovering target cells using degradable three dimensional matrices are described.Type: GrantFiled: May 16, 2013Date of Patent: May 30, 2017Assignee: Ingeneron, Inc.Inventors: Michael Coleman, Jody Vykoukal
-
Patent number: 9617344Abstract: A fusion protein including a targeting moiety, a cleavage site, and a cell membrane penetrating domain, a conjugate including the fusion protein and a bioactive molecule, and methods employing the fusion protein and the conjugate are provided.Type: GrantFiled: July 8, 2015Date of Patent: April 11, 2017Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Jae Il Lee, Soshin Ahn, Jung Min Kim, Jungmin Lee, Jung-Hoon Lee
-
Patent number: 9550981Abstract: Fusion proteins comprising a tafazzin peptide and a cellular permeability peptide are disclosed. The tafazzin peptide may be coupled to the permeability peptide through a polypeptide linker. Methods of making and using the fusion proteins are also disclosed. For example, the disclosed fusion proteins may be used to treat a patient having a disorder associated with a tafazzin deficiency or a remodeled cardiolipin deficiency (e.g., Barth syndrome). Additionally, the disclosed fusion proteins may be used in prophylaxis against developing a disorder associated with a tafazzin deficiency or a remodeled cardiolipin deficiency in a patient at risk of developing such a disorder.Type: GrantFiled: January 22, 2015Date of Patent: January 24, 2017Assignee: University of WashingtonInventors: Michael T. Chin, Wei-Ming Chien, Ana Dinca
-
Patent number: 9523070Abstract: A photobioreactor includes an input light delivery component and a plurality of photobioreactor media disposed in a stacked relationship, each of which is coupled to the input light delivery component, wherein each photobioreactor medium is adapted to be inoculated with a photosynthetic, biofuel-producing culture, further wherein each photobioreactor medium includes at least one hollow fiber membrane (HFM) disposed thereon in a region that is adapted to be inoculated with the photosynthetic, biofuel-producing culture, that can transport at least one of a gas and a photobioreactor product producible by the photosynthetic, biofuel-producing culture, wherein each photobioreactor medium is characterized by an input light-scattering mechanism.Type: GrantFiled: March 7, 2014Date of Patent: December 20, 2016Assignee: CORNELL UNIVERSITYInventors: David Erickson, Largus Angenent, Devin Doud, Erica Jung, Michael Kalontarov
-
Patent number: 9458515Abstract: An RNA of the present invention is an RNA containing a 5? cap structure and a coding region having a 5? initiation codon and a 3? stop codon on both ends of the coding region, the RNA having a nucleoside compound introduced at a site selected from among the 5? cap structure and 10 bases from a 5? end of the RNA, wherein the nucleoside compound is such that a group is attached to (i) a carbon atom at position 8 of a purine nucleus or (ii) a carbon atom at position 5 or 6 of a pyrimidine nucleus, the group being represented by formula (I): A-X?X-#??(I) where A represents an aryl group or a heteroaryl group, # represents a site where the group represented by the formula (I) is attached to the carbon atom at the position 8 of the purine nucleus or the carbon atom at the position 5 or 6 of the pyrimidine nucleus, and two Xs, which are identical to or different from each other, each represents a nitrogen atom or CH whose H may be substituted by alkyl.Type: GrantFiled: February 18, 2011Date of Patent: October 4, 2016Assignee: RIKENInventors: Shinji Ogasawara, Mizuo Maeda
-
Patent number: 9402814Abstract: A method is described including passing a solution having a biodegradable polymer, a solvent and a treatment agent through an electrocharged nozzle to form particles encapsulating the treatment agent. The particles emitted from the electrocharged nozzle may be exposed to a charge opposite that of the nozzle. The particles may be deposited in a collection assembly comprising a liquid phase. A further method including combining a biodegradable polymer, a solvent and a treatment agent to form a solution, electrodepositing the solution in a particle form wherein the particles encapsulate the treatment agent in a collection assembly comprising a liquid phase and mixing the particles with a bioerodible material capable of forming a gel is described. An apparatus having an electrocharged nozzle, a grounded electrode having an opposite charge to that of the nozzle and a collection assembly comprising a liquid phase is further disclosed.Type: GrantFiled: June 9, 2014Date of Patent: August 2, 2016Assignee: Abbott Cardiovascular Systems Inc.Inventors: Shubhayu Basu, Eugene T. Michal
-
Patent number: 9228261Abstract: A method and apparatus are provided for constructing tissue from cells or other objects by application of temporally and spatially controlled electric fields. Electric field applicators expose a substrate (32) to the electric field controlled to affect the processing medium (28) to achieve a processing effect on the construction of tissue on the substrate (32). Electrical bias is selected to interact with dipole properties of the medium (28) to control the movement of suspended dielectrophoretic cells or other particles in the medium (28) or at the substrate (32). The motion of suspended particles may be affected to cause suspended particles of different properties to follow different paths in the processing medium (28), which may be used to cause the suspended particles to be sorted. The processing medium (28) and electrical bias may be selected to affect the structure, or orientation, of one or more layers on the substrate (32).Type: GrantFiled: July 31, 2012Date of Patent: January 5, 2016Assignee: Tokyo Electron LimitedInventor: Jozef Brcka
-
Patent number: 9217180Abstract: Disclosed are an oligonucleotide primer with an omega structure for detecting short-chain RNAs and the use thereof. The primer from the 5? end to the 3? end sequentially is: a PCR primer target region of 20-30 bases, a variable coding region of 0-50 bases, an omega stem-loop, a probe spacer of at least one base and a probe region of 4-11 bases. The length of the stem of the omega stem-loop is 4-12 paired bases, and the length of the loop of the omega stem-loop is 3-20 unpaired bases.Type: GrantFiled: January 16, 2013Date of Patent: December 22, 2015Assignee: Chengdu Nuoen Biological Technology Co., Ltd.Inventors: Songbo Zhang, Guobiao Jiang, Fang Tang, Feifei Zhang
-
Patent number: 9206416Abstract: The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.Type: GrantFiled: October 30, 2013Date of Patent: December 8, 2015Assignee: BIOLOGICAL DYNAMICS, INC.Inventors: Rajaram Krishnan, David Charlot, Eugene Tu, James McCanna, Lucas Kumosa, Paul Swanson, Robert Turner, Kai Yang, Irina Dobrovolskaya, David Liu
-
Patent number: 9040272Abstract: The present invention provides a method and system for using eye-safe infrared energy from a Class I laser to manipulate cells in culture. The laser energy produces one or more phase boundary propulsion events, which generate hydrodynamic forces sufficient to manipulate cells at the focal point.Type: GrantFiled: June 13, 2011Date of Patent: May 26, 2015Assignee: Hamilton Thorne, Inc.Inventors: Diarmaid H. Douglas-Hamilton, Thomas G. Kenny
-
Patent number: 9034578Abstract: The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.Type: GrantFiled: October 7, 2014Date of Patent: May 19, 2015Assignee: BIOLOGICAL DYNAMICS, INC.Inventors: Rajaram Krishnan, David Charlot, Eugene Tu, James McCanna, Lucas Kumosa, Paul Swanson, Robert Turner, Kai Yang, Irina Dobrovolskaya, David Liu
-
Patent number: 9034622Abstract: The invention relates to a preparation for the photodynamic control of micro-organisms, said preparation being in a liquid or pasty form and containing a photosensitizer which comprises a dyestuff and produces singlet oxygen when irradiated by means of light. The micro-organisms can be marked by means of the dyestuff. The aim of the invention is to improve said preparation in order to enable an improved photodynamic control. To this end, the preparation contains an active ingredient for amplifying or weakening the oxidative action of the singulet oxygen by chemical manipulation of the dyestuff or the nanoenvironment thereof. In a particular form of embodiment, a rinsing solution is used before the irradiation.Type: GrantFiled: July 20, 2010Date of Patent: May 19, 2015Assignee: bredent medical GmbH & Co. KGInventors: Freimut Vizethum, Reinhold Schuetze
-
Patent number: 9034579Abstract: The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.Type: GrantFiled: October 10, 2014Date of Patent: May 19, 2015Assignee: BIOLOGICAL DYNAMICS, INCInventors: Rajaram Krishnan, David J. Charlot, Eugene Tu, James McCanna, Lucas Kumosa, Paul D. Swanson, Robert Turner, Kai Yang, Irina Dobrovolskaya, David Liu, Juan Pablo Hinestrosa Salazar, Juscilene Menezes
-
Patent number: 9034254Abstract: Disclosed is an antibacterial composition comprising titanium oxide particles immobilized with an antibody having affinity and cognitive power to a microorganism of interest, and a method for sterilizing the microorganism by using the same. In particular, the present invention relates to a method for preparing functional titanium oxide particles capable of recognizing a microorganism or a virus of interest, and a method for selectively and efficiently sterilizing the same by using the functional titanium oxide particles, and not for randomly sterilizing microorganisms or viruses by using conventional titanium oxide particles having no recognition power to a microorganism or a virus of interest.Type: GrantFiled: November 8, 2012Date of Patent: May 19, 2015Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Byoung Chan Kim, Jong Soo Jurng, Min Young Song
-
Publication number: 20150133466Abstract: The invention provides methods for overriding cell cycle arrest in a tumor cell, which comprise inducing DNA damage in the cell, and contacting the cell with an amount of bosutinib or a bosutinib isomer effective to inhibit one or more kinase constituents of a DNA damage checkpoint pathway. The invention also provides novel bosutinib isomers, as well as compositions of the novel isomers and the bosutinib isomer 3,5-dichloro-4-methoxyaniline.Type: ApplicationFiled: December 9, 2014Publication date: May 14, 2015Inventors: Timothy Yen, Neil Beeharry
-
Patent number: 9029108Abstract: A pulsed electric field method for the continuous extraction of oil and lipids from small aquatic plants, the method including providing a continuous flow of a slurry of small aquatic plants. A continuous flow of small aquatic plants is directed to a treatment zone. Pulsed electric fields are applied to the treatment zone to lyse cell walls of the small aquatic plants to enhance extraction of oil and lipids therefrom.Type: GrantFiled: September 15, 2010Date of Patent: May 12, 2015Assignee: Diversified Technologies, Inc.Inventors: Michael Alan Kempkes, Ian Roth, Marcel Pierre Joseph Gaudreau
-
Patent number: 9023787Abstract: The present invention relates to compounds and pharmaceutical compositions for treating cellular proliferative disorders, e.g., in patients having one or more p53-deficient cells, screening assays for identifying such compounds, and methods for treating such disorders.Type: GrantFiled: May 13, 2013Date of Patent: May 5, 2015Assignee: Massachusetts Institute of TechnologyInventors: Michael B. Yaffe, Isaac A. Manke, Hans Christian Reinhardt
-
Publication number: 20150119448Abstract: The present invention relates to small RNAs, inhibitors thereof, inhibitors of enzymes producing thereof, and their use to modulate the response of a cell to a DNA damaging event. The invention concerns also a method to detect the presence or quantify DNA damage.Type: ApplicationFiled: May 10, 2013Publication date: April 30, 2015Inventors: Fabrizio D'Adda Di Fagagna, Sofia Francia, Flavia Michelini, Francesca Rossiello
-
Patent number: 9018013Abstract: The present invention provides compositions and methods for the genetic manipulation of Algal cells. The compositions and methods allow enhanced transfer of genetic material into Algal cells and the cloning and selection of genetically modified cells. Expression of proteins encoded by the genetic material will be enhanced by the methods and compositions of the invention.Type: GrantFiled: August 13, 2012Date of Patent: April 28, 2015Assignee: Life Technologies CorporationInventors: Farzad Haerizadeh, Todd Peterson, Wen Chen, Ewa Lis